Skip to main content
. 2021 Sep 29;8(2):e001789. doi: 10.1136/openhrt-2021-001789

Table 2.

MYBPC3 c.2149–1G>A and MYBPC3 p.Arg502Tr/Gln cardiac MR data

MYBPC3
c.2149–1G>A
MYBP3
p.Arg502Trp/Gln
P value
Male Female Total Male Female Total
N 10 4 14 12 6 18
LVEDV (mean±SD, mL) 188±47 144±18 175±45 195±57 178±39 190±51 0.407
LVESV (mean±SD, mL) 83±26 55±18 75±27 98±33 86±53 94±39 0.128
EF (mean±SD, %) 56±12 63±8 58±11 49±14 55±17 51±15 0.163
LV mass (mean±SD, g) 151±47 91±15 134±48 161±72 103±16 142±65 0.669
LV mass index (mean±SD, g per m2) 78±36 50±6 65±29 84±36 53±5 77±34 0.399
Fibrotic mass (mean±SD, g) 38±49 12±7 31±43 39±42 37±26 38±36 0.620
Fibrotic mass index (mean±SD, g per m2) 27±39 7±5 18±30 20±21 22±21 21±20 0.798
% fibrosis (mean±SD, %) 17±17 12±6 16±14 20±14 28±17 23±15 0.195

LVEDV, left ventricular end-diastolic volume; LVESV, left ventricular end-systolic volume; EF, ejection fraction.